These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 7588274)

  • 1. A conformational change in the beta-subunit of the insulin-like growth factor I receptor identified by antipeptide antibodies.
    Gual P; Baron V; Alengrin F; Van Obberghen E
    Endocrinology; 1995 Dec; 136(12):5298-304. PubMed ID: 7588274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antipeptide antibody to the insulin-like growth factor-I receptor sequence 1232-1246 inhibits the receptor kinase activity.
    Kaliman P; Baron V; Gautier N; Van Obberghen E
    J Biol Chem; 1992 May; 267(15):10645-51. PubMed ID: 1316907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A developmentally regulated form of insulin-like growth factor receptor beta-subunit in C2 myoblasts exhibiting altered requirements for differentiation.
    Barenton B; Domeyne A; Garandel V; Garofalo RS
    Endocrinology; 1993 Aug; 133(2):651-60. PubMed ID: 8344204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single tyrosine substitution in the insulin-like growth factor I receptor inhibits ligand-induced receptor autophosphorylation and internalization, but not mitogenesis.
    Stannard B; Blakesley V; Kato H; Roberts CT; LeRoith D
    Endocrinology; 1995 Nov; 136(11):4918-24. PubMed ID: 7588225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Essential role of tyrosine residues 1131, 1135, and 1136 of the insulin-like growth factor-I (IGF-I) receptor in IGF-I action.
    Kato H; Faria TN; Stannard B; Roberts CT; LeRoith D
    Mol Endocrinol; 1994 Jan; 8(1):40-50. PubMed ID: 7512194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinase inhibition by a phosphorylated peptide corresponding to the major insulin receptor autophosphorylation domain.
    Chavanieu A; Calas B; Vaglio P; Grigorescu F
    Eur J Biochem; 1992 Sep; 208(2):367-73. PubMed ID: 1381676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumorigenic and mitogenic capacities are reduced in transfected fibroblasts expressing mutant insulin-like growth factor (IGF)-I receptors. The role of tyrosine residues 1250, 1251, and 1316 in the carboxy-terminus of the IGF-I receptor.
    Blakesley VA; Kalebic T; Helman LJ; Stannard B; Faria TN; Roberts CT; LeRoith D
    Endocrinology; 1996 Feb; 137(2):410-7. PubMed ID: 8593783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of insulin-like growth factor (IGF)-binding protein-3 and its proteolytic fragments on ligand binding, cell surface association, and IGF-I receptor signaling.
    Devi GR; Yang DH; Rosenfeld RG; Oh Y
    Endocrinology; 2000 Nov; 141(11):4171-9. PubMed ID: 11089550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epitope mapping of the alpha-chain of the insulin-like growth factor I receptor using antipeptide antibodies.
    Delafontaine P; Ku L; Ververis JJ; Cohen C; Runge MS; Alexander RW
    J Mol Cell Cardiol; 1994 Dec; 26(12):1659-73. PubMed ID: 7731060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin receptor-induced phosphorylation of cellular and synthetic substrates is regulated by the receptor beta-subunit C-terminus.
    Gual P; Baron V; Alengrin F; Mothe I; Van Obberghen E
    Endocrinology; 1996 Aug; 137(8):3416-23. PubMed ID: 8754769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of insulin-like growth factor I receptor tyrosine kinase by ethanol.
    Rubin R; Harrison R; Chen XF; Corzitotto J; Hoek JB; Hallak H
    Biochem Pharmacol; 2004 Nov; 68(10):2009-17. PubMed ID: 15476672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tyrosine residues in the C-terminal domain of the insulin-like growth factor-I receptor mediate mitogenic and tumorigenic signals.
    Esposito DL; Blakesley VA; Koval AP; Scrimgeour AG; LeRoith D
    Endocrinology; 1997 Jul; 138(7):2979-88. PubMed ID: 9202243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drosophila insulin receptor: lectin-binding properties and a role for oxidation-reduction of receptor thiols in activation.
    Marin-Hincapie M; Garofalo RS
    Endocrinology; 1995 Jun; 136(6):2357-66. PubMed ID: 7750456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of insulin and insulin-like growth factor-I actions in the bovine luteal cell: regulation of receptor tyrosine kinase activity, phosphatidylinositol-3-kinase, and deoxyribonucleic acid synthesis.
    Chakravorty A; Joslyn MI; Davis JS
    Endocrinology; 1993 Sep; 133(3):1331-40. PubMed ID: 8396016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autophosphorylation of the insulin-like growth factor I receptor cytoplasmic domain.
    Lopaczynski W; Terry C; Nissley P
    Biochem Biophys Res Commun; 2000 Dec; 279(3):955-60. PubMed ID: 11162456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential phosphorylation of pp120 by insulin and insulin-like growth factor-1 receptors: role for the C-terminal domain of the beta-subunit.
    Najjar SM; Blakesley VA; Li Calzi S; Kato H; LeRoith D; Choice CV
    Biochemistry; 1997 Jun; 36(22):6827-34. PubMed ID: 9184166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structure of bisphosphorylated IGF-1 receptor kinase: insight into domain movements upon kinase activation.
    Pautsch A; Zoephel A; Ahorn H; Spevak W; Hauptmann R; Nar H
    Structure; 2001 Oct; 9(10):955-65. PubMed ID: 11591350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autophosphorylation of the insulin receptor in vitro. Designation of phosphorylation sites and correlation with receptor kinase activation.
    Herrera R; Rosen OM
    J Biol Chem; 1986 Sep; 261(26):11980-5. PubMed ID: 3745176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the insulin-like growth factor type 1 receptor by deletion of amino acids 870-905.
    Li S; Zhang H; Hoff H; Sell C
    Exp Cell Res; 1998 Sep; 243(2):326-33. PubMed ID: 9743592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An antipeptide antibody that specifically inhibits insulin receptor autophosphorylation and protein kinase activity.
    Herrera R; Petruzzelli L; Thomas N; Bramson HN; Kaiser ET; Rosen OM
    Proc Natl Acad Sci U S A; 1985 Dec; 82(23):7899-903. PubMed ID: 2415975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.